These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 28225510

  • 1. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
    Shimojima Y, Ishii W, Matsuda M, Kishida D, Ikeda SI.
    J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis.
    Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, Eguchi K.
    Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T, Yasuda S, Amengual O, Atsumi T.
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [Abstract] [Full Text] [Related]

  • 8. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
    Mira-Avendano IC, Parambil JG, Yadav R, Arrossi V, Xu M, Chapman JT, Culver DA.
    Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
    Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S, Kurihara Y, Osada H, Satoh M, Ozaki S.
    Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
    Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, Lundberg IE.
    Arthritis Rheum; 2008 May 15; 59(5):677-85. PubMed ID: 18438901
    [Abstract] [Full Text] [Related]

  • 15. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.
    Fathi M, Barbasso Helmers S, Lundberg IE.
    J Intern Med; 2012 Jun 15; 271(6):589-97. PubMed ID: 21950266
    [Abstract] [Full Text] [Related]

  • 16. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I.
    J Rheumatol; 1999 Jul 15; 26(7):1527-33. PubMed ID: 10405940
    [Abstract] [Full Text] [Related]

  • 17. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
    Takada K, Katada Y, Ito S, Hayashi T, Kishi J, Itoh K, Yamashita H, Hirakata M, Kawahata K, Kawakami A, Watanabe N, Atsumi T, Takasaki Y, Miyasaka N.
    Rheumatology (Oxford); 2020 May 01; 59(5):1084-1093. PubMed ID: 31539061
    [Abstract] [Full Text] [Related]

  • 18. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
    Bartosiewicz M, Siemion-Szcześniak I, Sobiecka M, Wyrostkiewicz D, Radwan-Röhrenschef P, Lewandowska K, Langfort R, Oniszh K, Franczuk M, Kuś J.
    Pneumonol Alergol Pol; 2013 May 01; 81(6):556-66. PubMed ID: 24142786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T.
    Respir Investig; 2017 Mar 01; 55(2):130-137. PubMed ID: 28274528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.